Menu Back toS47-Toward-to-Development-of-Comprehensive-and-Reliable-Drug-Information-System-for-Consumers-and-Patients

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe


[S47] Toward to Development of Comprehensive and Reliable Drug Information System for Consumers and Patients

Session Chair(s)

Michiko  Yamamoto, PhD

Michiko Yamamoto, PhD

  • Visiting Professor
  • Kumamoto University, Japan
While pharmaceutical information is abundant on the media and the Internet, people do not know where they can obtain the correct information. When we evaluated medical information on the Internet based on international evaluation criteria etc., few sites met the criteria in Japan. It may be considered that the scheme for securing whether it is reliable information is not spreading. Pharmaceutical information does not provide sufficiently for the general public in the flow from clinical trial, approval to post-marketing. It is required to develop the comprehensive information infrastructure for shared decision making, considering the consumers and patients’ health literacy. It should be necessary to discuss the prospects and issues from the perspective of industry, government, academia and patients.

Speaker(s)

Takeo  Nakayama, MD, PhD

Takeo Nakayama, MD, PhD

  • Professor, Department of Health Informatics, School of Public Health
  • Kyoto University, Japan
Kazuhiro  Keitoku

Kazuhiro Keitoku

  • Director, Product Safety, Japan Drug Safety Unit
  • Pfizer Japan Inc., Japan
Michiko  Yamamoto, PhD

Michiko Yamamoto, PhD

  • Visiting Professor
  • Kumamoto University, Japan